BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 15094376)

  • 1. Actin--an inhibitor of eukaryotic elongation factor activities.
    Bektaş M; Günçer B; Güven C; Nurten R; Bermek E
    Biochem Biophys Res Commun; 2004 May; 317(4):1061-6. PubMed ID: 15094376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous ADP-ribosylation for eukaryotic elongation factor 2: evidence of two different sites and reactions.
    Bektaş M; Nurten R; Ergen K; Bermek E
    Cell Biochem Funct; 2006; 24(4):369-80. PubMed ID: 16142694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytoplasmic inhibitor of eEF-2 ADP-ribosylation catalyzed by diphtheria toxin or endogenous transferase in rat liver cells.
    Galicka A; Sredzińska K; Gindzieński A
    Biochem Biophys Res Commun; 2000 Mar; 269(2):553-6. PubMed ID: 10708592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxidative stress on in vivo ADP-ribosylation of eukaryotic elongation factor 2.
    Bektaş M; Akçakaya H; Aroymak A; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2005 Jan; 37(1):91-9. PubMed ID: 15381153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous ADP-ribosylation of eukaryotic elongation factor 2 and its 32 kDa tryptic fragment.
    Ergen K; Bektaş M; Gökçe S; Nurten R
    Biocell; 2007; 31(1):61-6. PubMed ID: 17665640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transition state structure for ADP-ribosylation of eukaryotic elongation factor 2 catalyzed by diphtheria toxin.
    Parikh SL; Schramm VL
    Biochemistry; 2004 Feb; 43(5):1204-12. PubMed ID: 14756556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction between actin and FA fragment of diphtheria toxin.
    Unlü A; Bektaş M; Sener S; Nurten R
    Mol Biol Rep; 2013 Apr; 40(4):3135-45. PubMed ID: 23271118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of diphtheria toxin (fragment A) with actin.
    Bektaş M; Varol B; Nurten R; Bermek E
    Cell Biochem Funct; 2009 Oct; 27(7):430-9. PubMed ID: 19711484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mode of inhibition of eukaryotic protein synthesis by ADP-ribosylation of elongation factor 2.
    Nurten R; Albeniz I; Bermek E
    IUBMB Life; 1999 Nov; 48(5):557-62. PubMed ID: 10637774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The eukaryotic elongation factor EF-2 loses its nonspecific affinity for RNA as a result of ADP ribosylation].
    Bezlepkina TA; Davydova EK; Sitikov AS; Vertiev IuA; Ezepchuk IuV
    Dokl Akad Nauk SSSR; 1984; 278(3):751-4. PubMed ID: 6209075
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of cytochalasin D-stimulated G-actin ATPase by ADP-ribosylation with Clostridium perfringens iota toxin.
    Geipel U; Just I; Aktories K
    Biochem J; 1990 Mar; 266(2):335-9. PubMed ID: 2138453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of protein synthesis by didemnin B: how EF-1alpha mediates inhibition of translocation.
    Ahuja D; Vera MD; SirDeshpande BV; Morimoto H; Williams PG; Joullié MM; Toogood PL
    Biochemistry; 2000 Apr; 39(15):4339-46. PubMed ID: 10757982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of localization of the protein-synthesizing machinery along actin filament bundles.
    Shestakova EA; Motuz LP; Minin AA; Gavrilova LP
    Cell Biol Int; 1993 Apr; 17(4):409-16. PubMed ID: 8318952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating the ADP-ribosyltransferase activity of sirtuins with NAD analogues and 32P-NAD.
    Du J; Jiang H; Lin H
    Biochemistry; 2009 Apr; 48(13):2878-90. PubMed ID: 19220062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the nature of cellular ADP-ribosyltransferase from rat liver specific for elongation factor 2.
    Sayhan O; Ozdemirli M; Nurten R; Bermek E
    Biochem Biophys Res Commun; 1986 Sep; 139(3):1210-4. PubMed ID: 3094526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of non-ADP-ribosylatable, diphtheria toxin-resistant elongation factor 2 in Saccharomyces cerevisiae.
    Kimata Y; Harashima S; Kohno K
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1145-51. PubMed ID: 8466491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of additional charges as an aid in protein purification: isolation of elongation factor 2 from Sulfolobus acidocaldarius by preparative isoelectric focusing before and after ADP-ribosylation.
    Siegmund KD; Klink F
    Protein Expr Purif; 1994 Dec; 5(6):553-8. PubMed ID: 7858424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On diphtheria toxin fragment A release into the cytosol--cytochalasin D effect and involvement of actin filaments and eukaryotic elongation factor 2.
    Bektaş M; Hacıosmanoğlu E; Ozerman B; Varol B; Nurten R; Bermek E
    Int J Biochem Cell Biol; 2011 Sep; 43(9):1365-72. PubMed ID: 21664484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eukaryotic elongation factor-2 (eEF-2) activity in bovine mammary tissue in relation to milk protein synthesis.
    Christophersen CT; Karlsen J; Nielsen MO; Riis B
    J Dairy Res; 2002 May; 69(2):205-12. PubMed ID: 12222799
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1β effect on the endogenous ADP-ribosylation and phosphorylation of eukaryotic elongation factor 2.
    Hacıosmanoğlu E; Varol B; Edis BÖ; Bektaş M
    Cytotechnology; 2016 Dec; 68(6):2659-2666. PubMed ID: 27510652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.